| |
| |
|
| Insider
Information: |
Shaaltiel Yoseph |
| Relationship: |
Executive VP, R&D |
| City: |
Carmiel, Israel |
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
585,916 |
|
|
Indirect Shares
|
210,000 |
|
|
| Direct
Value |
$155,033 |
|
|
|
Indirect Value
|
$55,566 |
|
|
| Total
Shares |
795,916 |
|
|
| Total
Value |
$210,599 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Protalix Biotherapeutics |
PLX |
Executive VP, R&D |
2016-09-15 |
585,916 |
2016-09-15 |
210,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PLX |
Protalix Biotherapeutics |
Executive VP, R&D |
• – – |
2016-09-15 |
4 |
OE |
$0.00 |
$122 |
D/D |
122,162 |
585,916 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
Executive VP, R&D |
• • – |
2012-07-16 |
4 |
A |
$0.00 |
$0 |
I/I |
210,000 |
210,000 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
Executive VP, R&D |
• • – |
2010-08-06 |
4 |
AS |
$7.00 |
$32,333 |
D/D |
(4,619) |
763,754 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
Executive VP, R&D |
• • – |
2010-08-05 |
4 |
AS |
$7.00 |
$338,856 |
D/D |
(48,408) |
768,373 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
Executive VP, R&D |
• • – |
2010-06-21 |
4 |
AS |
$7.00 |
$370,811 |
D/D |
(52,973) |
816,781 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
Executive VP, R&D |
• • – |
2010-04-14 |
4 |
AS |
$7.00 |
$9,163 |
D/D |
(1,309) |
882,445 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
Executive VP, R&D |
• • – |
2010-03-25 |
4 |
AS |
$7.00 |
$350,000 |
D/D |
(50,000) |
883,754 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
Executive VP, R&D |
• • – |
2010-03-24 |
4 |
AS |
$7.08 |
$1,435,116 |
D/D |
(202,700) |
933,754 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
Executive VP, R&D |
• • – |
2010-03-23 |
4 |
AS |
$7.02 |
$893,646 |
D/D |
(127,300) |
1,136,454 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
Executive VP, R&D |
• • – |
2009-10-19 |
4 |
AS |
$9.43 |
$406,622 |
D/D |
(43,120) |
1,263,754 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
Executive VP, R&D |
• • – |
2009-10-16 |
4 |
AS |
$9.39 |
$241,135 |
D/D |
(25,680) |
1,306,874 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
Executive VP, R&D |
• • – |
2009-10-15 |
4 |
AS |
$9.39 |
$292,968 |
D/D |
(31,200) |
1,332,554 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
Executive VP, R&D |
• • – |
2009-07-06 |
4 |
AS |
$4.95 |
$509,400 |
D/D |
(100,000) |
1,363,754 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
Executive VP, R&D |
• • – |
2009-05-14 |
4 |
S |
$3.85 |
$38,500 |
D/D |
(10,000) |
1,463,754 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
Executive VP, R&D |
• • – |
2009-05-13 |
4 |
S |
$3.51 |
$70,200 |
D/D |
(20,000) |
1,473,754 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
Executive VP, R&D |
• • – |
2009-03-13 |
4 |
S |
$2.18 |
$18,094 |
D/D |
(8,300) |
1,493,754 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
Executive VP, R&D |
• • – |
2007-12-19 |
4 |
B |
$3.40 |
$16,320 |
D/D |
4,800 |
2,974,107 |
2.81 |
- |
|
| PLX |
Protalix Biotherapeutics |
Executive VP, R&D |
• • – |
2007-12-18 |
4 |
B |
$3.35 |
$17,335 |
D/D |
5,100 |
2,969,307 |
2.81 |
- |
|
| PLX |
Protalix Biotherapeutics |
Executive VP, R&D |
• • – |
2007-12-17 |
4 |
B |
$3.35 |
$16,750 |
D/D |
5,000 |
2,964,207 |
2.81 |
- |
|
| PLX |
Protalix Biotherapeutics |
Executive VP, R&D |
• • – |
2007-12-05 |
4 |
B |
$3.05 |
$47,388 |
D/D |
15,100 |
2,959,207 |
2.81 |
- |
|
| PLX |
Protalix Biotherapeutics |
Executive VP, R&D |
• • – |
2006-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,944,107 |
2,944,107 |
0 |
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
